Código QR (código de barras bidimensional)

Case report: Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse event

There are very few therapeutic options to treat patients with locally advanced or metastatic Urothelial Cancer (UC). Enfortumab vedotin (EV) was recently approved by the FDA and has become a new therapeutic option for patients previously managed with conventional treatments. Despite its efficacy, EV...

Fuld beskrivelse

Na minha lista:
Principais autores: Astha Koolwal Kapoor, Carleton S. Ellis, Deepali Pandey, Derek B. Allison, Zin W. Myint
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2024-02-01
Serier:Frontiers in Oncology
Fag:
diabetes ketoacidosis
CRRT
insulin
enfortumab vedotin
maculopapular rash
liver failure
Online adgang:https://www.frontiersin.org/articles/10.3389/fonc.2024.1332478/full
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker